HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of alpha-difluoromethylornithine-induced polyamine depletion on the radiosensitivity of a human colon carcinoma cell line.

Abstract
The effect of the polyamine biosynthesis inhibitor alpha-difluoromethylornithine (DFMO) on the in vitro radiation response of Clone A human colon adenocarcinoma cells was investigated. Analysis of intracellular polyamine levels showed that exposure of Clone A cells to 1 mM DFMO for 96 h reduced putrescine and spermidine to nondetectable levels, while spermine was decreased by approximately 50%. This DFMO treatment protocol enhanced the radiosensitivity of Clone A cells, which was reflected by a decrease in both the Do and Dq. The addition of putrescine (1 mM) for the final 48 h of DFMO exposure restored polyamine levels and returned clone A radiosensitivity to that of control cells. These results indicate that polyamine depletion by DFMO sensitizes Clone A tumor cells to ionizing radiation.
AuthorsC M Arundel, K Nishioka, P J Tofilon
JournalRadiation research (Radiat Res) Vol. 114 Issue 3 Pg. 634-40 (Jun 1988) ISSN: 0033-7587 [Print] United States
PMID3131831 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Cesium Radioisotopes
  • Polyamines
  • Eflornithine
Topics
  • Cell Line
  • Cell Survival (drug effects, radiation effects)
  • Cesium Radioisotopes
  • Colonic Neoplasms (pathology)
  • Eflornithine (pharmacology)
  • Gamma Rays
  • Humans
  • Polyamines (biosynthesis)
  • Radiation Tolerance
  • Tumor Cells, Cultured (drug effects, radiation effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: